Gi bleeding treathment

Not Applicable

• Conditions: pper gibleeding.; Gastrointestinal haemorrhage, unspecified

• Registration Number: IRCT2013050713261N1
• Lead Sponsor: Personal

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 114

Inclusion Criteria

The patients with upper gastrointestinal bleeding and treated by epinephrine injection who wanted to participate in the study and do not had allergy to the
underwent urgent endoscopy within 24 h after
presentation, had peptic ulcers in the distal oesophagus, stomach or duodenum, had high-risk stigmata including active bleeding , nonbleeding visible vessels , or adherent clots , and successful haemostasis was achieved with endoscopic injection of epinephrine. Written informed consent was obtained before enrolment.
Exclusion criteria:
pregnant; did not obtain initial haemostasis with endoscopic
injection of epinephrine; did not give written
informed consent; had bleeding tendency (platelet count
<50000 , PT > 3 s of normal, CT and BT prolong or were
taking anticoagulants); had uraemia ; bleeding gastric cancer.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
o reebleeding. Timepoint: 72h. Method of measurement: patient Symptoms and endoscopy in second 24 h.

Secondary Outcome Measures

Name	Time	Method
Hospital stay and mortality and blood transfusion. Timepoint: 72h. Method of measurement: symptoms.